HIV/AIDS Topics No New HIV Infections Among Kaiser PrEP Users, But Cascade Shows Missed Opportunities
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 21 September 2017 00:00
- Written by Liz Highleyman
No new HIV infections have occurred among nearly 5000 people who started Truvada for pre-exposure prophylaxis (PrEP) in the Kaiser Permanente Northern California health system, according to a letter in the July 29 edition of Clinical Infectious Diseases.
IAS 2017: Experts Agree that Intermittent Oral PrEP Probably Won't Work for Women
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 21 September 2017 00:00
- Written by Gus Cairns
Two presenters at the recent International AIDS Society Conference on HIV Science (IAS 2017) in Paris told delegates that both trial results and analysis of drug levels support the idea that event-related or "on demand" pre-exposure prophylaxis (PrEP) might not be sufficiently powerful to prevent HIV infection in women and trans men via vaginal sex.
IAS 2017: Medical Male Circumcision for HIV Prevention Has Benefits for Women Too
- Details
- Category: Circumcision
- Published on Thursday, 17 August 2017 00:00
- Written by Roger Pebody
South African women whose most recent sexual partner was circumcised are less likely to have HIV, suggesting that voluntary medical male circumcision programs have benefits for women, too, according to a study presented to the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.
IAS 2017: PrEP Use in U.S. Exceeds 100,000 in Gilead Pharmacy Survey
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 17 August 2017 00:00
- Written by Liz Highleyman
An estimated 120,000 people in the U.S. have started Truvada (tenofovir/emtricitabine) for pre-exposure prophylaxis (PrEP) since 2012, according to the latest findings from a survey of retail and mail-order pharmacies by Gilead Sciences, presented at the recent 9th IAS Conference on HIV Science (IAS 2017) in Paris.
IAS 2017: Demonstration Projects Explore Feasibility of PrEP for Adolescents in South Africa
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 09 August 2017 00:00
- Written by Roger Pebody
One of the first studies to explore the acceptability, safety, and use of pre-exposure prophylaxis (PrEP) in adolescents in an African context has found that PrEP was safe and tolerable, although PrEP usage and adherence did tail off during the 12 months of the program.
Web Design and Development by